陈士岭. 卵巢储备功能的评价 [J]. 国际生殖健康/计划生育杂志, 2009(5):281.
|
Kyrou D, Kolibianakis E M, Venetis C A. How to im-prove the probability of pregnancy in poor responders under-going in vitro fertilization:a systematic review and meta anal-ysis [J]. Fertility and Sterility, 2009(3):749.
|
李敏, 俞炽阳, 李玉艳. 体外受精-胚胎移植术后重度卵巢过度刺激综合征、双胎、胎儿畸形引产 1 例 [J]. 第三军医大学学报, 2013, (25):2609.
|
梁静, 孙维峰, 周建龙. 复方多囊调经汤治疗多囊卵巢综合征的机制研究 [J]. 华南国防医学杂志, 2013(6):397.
|
莫爱萍. 抑制素 A 和抑制素 B 对卵巢早衰的诊断价值研究 [J]. 海南医学院学报, 2011(9):1239.
|
李跃萍. 人类卵巢组织冻存与移植 [J]. 海南医学院学报, 2011(4):574.
|
刘阳, 蔡霞. 卵巢储备功能与辅助生殖技术治疗结局 [J]. 国际生殖健康/计划生育杂志, 2009(5):305.
|
Burger H G. Androgen production in women [J]. Fertil Ster-il, 2002(4):S3.
|
Fusi F M, Ferrario M, Bosisio C. DHEA supplemen-tation positively affects spontaneous pregnancies in women with diminishedovarian function [J]. Gynecological Endocrinology, 2013, (10):940.
|
Narkwichean A, Maalouf W, Campbel B K. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminishedovarian reserve:a meta-analysis [J]. Reproductive Biology and Endocrinology, 2013.44.
|
Wiser A, Gonen O, Ghetler Y, et aI. Addition of dehy-droepiandrosterone(DHEA)for poor responder patients be-fore and during IVF treatment improves the pregnancy rate:a randomized prospective study [J]. Human Reproduction, 2010, (10):2496.
|
Gleicher N, Weghfer A, Bared D H. Dchydroepiandmstemne (DHEA)reduces embryo aneuploidy:Direct evidence from preimplantation genetic screening (PGS) [J]. Repmd BiolEn-docrinol, 2010.140.
|
Yilmaz N, Uygur D, Inal H. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarianreserve:serum AMH, inhibin B and antral fol icle count [J]. European Journal of Obstetrics Gynecology and Reproductive Biology, 2013(2):257.
|
Borman E, Check J H, Mitchel-Wil iams J. No evi-dence to support the concept that low serum dehy-droepiandrosterone(DHEA)sulfate(s)levels are associated with less oocyte production or lower pregnancy rates [J]. Clinical and Experimental Obstetrics and Gynecology, 2012(4):429.
|
Kara M, Aydin T, Aran T. Does dehydroepi and ros-terone supplementation real y affect IVF-ICSI outcome in women with poorovarian reserve [J]. European Journal of Obstetrics Gynecology and Reproductive Biology, 2014.63.
|
Gleicher N, Weghofer A, Barad D. The perpetual y "young”oocyte:ovarian environments for fol icular maturation age but not unrecruited, resting primordial fol icles/oocytes [J]. Fer-til Steril, 2010(4):S139.
|
Gleicher N, Barad D H. Dehydreepiandrosterune (DHEA) supplementation in diminished ovarian resewe (DOR) [J]. Reproductive Biology and Endocrinology, 2011.67.
|
Hossein R B, Hormoz B, Shahrokh T E. Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI re-sults [J]. GynecolEndocrinol, 2009(3):194.
|
Yakin K, Urman B. DHEA as a miracle drug in the treat-ment of poor responders:hype or hope [J]. I Hum Repred, 2011(8):1941.
|
Urman B, Yakin K. Does dehydroepiandrosterone have any benefit in fertility treatment [J]. Current Opinion in Obstetrics & Gynecology, 2012(3):132.
|
Gleicher N, Weghofer A, Barad D H. Improvement in di-minished ovarian reserve after dehydroepiandrosterone supple-mentation [J]. Reproductive BioMedicine Online, 2010(3):360.
|
Gleicher N, Ryan E, Weghofer A. Miscarriage rates after dehydroepiandrosterone (DHEA)supplementation in women withdiminished ovarian reserve:a case control study [J]. Reproductive Biology and Endocrinology, 2009.108.
|